Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001144204-18-033540
Filing Date
2018-06-08
Accepted
2018-06-08 16:07:19
Documents
5
Effectiveness Date
2018-06-08

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tv496075_s8.htm S-8 87959
2 EXHIBIT 5.1 tv496075_ex5-1.htm EX-5.1 8625
3 EXHIBIT 23.2 tv496075_ex23-2.htm EX-23.2 3959
4 GRAPHIC image_001.jpg GRAPHIC 2237
5 GRAPHIC image_002.jpg GRAPHIC 1762
  Complete submission text file 0001144204-18-033540.txt   107567
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-225526 | Film No.: 18889516
SIC: 2836 Biological Products, (No Diagnostic Substances)